Automated insulin delivery in children with type 1 diabetes during physical activity: a meta-analysis
Abstract
Objectives
The aim of this study was to evaluate the performance of the automated insulin delivery (AID) in adolescents, and children with type 1 diabetes (T1D) during physical activity.
Methods
Relevant studies were searched electronically in the Cochrane Library, PubMed, and Embase utilizing the key words “Child”, “Insulin Infusion Systems”, and “Diabetes Mellitus” from inception to 17th March 2024 to evaluate the performance of the AID in adolescents, and children with T1D during physical activity.
Results
Twelve studies involving 514 patients were identified. AID did not show a beneficial effect on duration of hypoglycemia<70 mg/dL during study period (p>0.05; I2=96 %) and during the physical activity (p>0.99). Percentage of sensor glucose values in TIR was higher in AID than the non-AID pumps during study period (p<0.001; I2=94 %). The duration of hyperglycemic time was significantly decreased in AID group compared to the non-AID pumps group during study period (p<0.05; I2>50 %).
Conclusions
AID improved TIR and decreased the duration of hyperglycemic time, but did not appear to have a significant beneficial effect on the already low post-exercise duration of hypoglycemia achievable by open loop or sensor-augmented pumps in adolescents and children with T1D during physical activity; further research is needed to confirm the beneficial effect of AID on duration of hypoglycemia.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: Yuan-yuan Wang and Chun-cong Zhou designed the study. Hui-min Ying, and Xiao-lu Qian did the work of data collecting, and data was analyzed by Fang Tian. Yuan-yuan Wang and Chun-cong Zhou wrote the paper. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: The authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: All data analysed during this study were collected from published articles [Table 1].
-
Trial registration: CRD42022367493; https://www.crd.york.ac.uk/PROSPERO, Principal investigator: Zhen-feng Zhou, Date of registration: October 30, 2022.
References
1. Zuberi, Z, Sauli, E, Cun, L, Deng, J, Li, WJ, He, XL, et al.. Insulin-delivery methods for children and adolescents with type 1 diabetes. Ther Adv Endocrinol Metab 2020;11:1–13. https://doi.org/10.1177/2042018820906016.Suche in Google Scholar PubMed PubMed Central
2. Colberg, SR, Sigal, RJ, Yardley, JE, Riddell, MC, Dunstan, DW, Dempsey, PC, et al.. Physical activity/exercise and diabetes: a position statement of the American diabetes association. Diabetes Care 2016;39:2065–79. https://doi.org/10.2337/dc16-1728.Suche in Google Scholar PubMed PubMed Central
3. Adolfsson, P, Nilsson, S, Albertsson-Wikland, K, Lindblad, B. Hormonal response during physical exercise of different intensities in adolescents with type 1 diabetes and healthy controls. Pediatr Diabetes 2012;13:587–96. https://doi.org/10.1111/j.1399-5448.2012.00889.x.Suche in Google Scholar PubMed
4. Metcalf, KM, Singhvi, A, Tsalikian, E, Tansey, JM, Zimmerman, MB, Esliger, DW, et al.. Effects of moderate-to-vigorous intensity physical activity on overnight and next-day hypoglycemia in active adolescents with type 1 diabetes. Diabetes Care 2014;37:1272–8. https://doi.org/10.2337/dc13-1973.Suche in Google Scholar PubMed PubMed Central
5. Sherr, JL, Schoelwer, M, Dos Santos, TJ, Reddy, L, Biester, T, Galderisi, A, et al.. ISPAD clinical practice consensus guidelines 2022: diabetes technologies: insulin delivery. Pediatr Diabetes 2022;23:1406–31. https://doi.org/10.1111/pedi.13421.Suche in Google Scholar PubMed
6. Jiao, X, Shen, Y, Chen, Y. Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis. BMJ Open Diabetes Res Care 2022;10. https://doi.org/10.1136/bmjdrc-2021-002633.Suche in Google Scholar PubMed PubMed Central
7. Jabari, M. Efficacy and safety of closed-loop control system for type one diabetes in adolescents a meta analysis. Sci Rep 2023;13:13165. https://doi.org/10.1038/s41598-023-40423-y.Suche in Google Scholar PubMed PubMed Central
8. Wadwa, RP, Reed, ZW, Buckingham, BA, DeBoer, MD, Ekhlaspour, L, Forlenza, GP, et al.. Trial of hybrid closed-loop control in young children with type 1 diabetes. N Engl J Med 2023;388:991–1001. https://doi.org/10.1056/nejmoa2210834.Suche in Google Scholar PubMed PubMed Central
9. Phillip, M, Battelino, T, Atlas, E, Kordonouri, O, Bratina, N, Miller, S, et al.. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824–33. https://doi.org/10.1056/nejmoa1206881.Suche in Google Scholar PubMed
10. Thabit, H, Tauschmann, M, Allen, JM, Leelarathna, L, Hartnell, S, Wilinska, ME, et al.. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015;373:2129–40. https://doi.org/10.1056/nejmoa1509351.Suche in Google Scholar
11. Sherr, JL, Cengiz, E, Palerm, CC, Clark, B, Kurtz, N, Roy, A, et al.. Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care 2013;36:2909–14. https://doi.org/10.2337/dc13-0010.Suche in Google Scholar PubMed PubMed Central
12. Elleri, D, Allen, JM, Kumareswaran, K, Leelarathna, L, Nodale, M, Caldwell, K, et al.. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36:838–44. https://doi.org/10.2337/dc12-0816.Suche in Google Scholar PubMed PubMed Central
13. Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 1995;18:1415–27. https://doi.org/10.2337/diacare.18.11.1415.Suche in Google Scholar PubMed
14. Ly, TT, Keenan, DB, Roy, A, Han, J, Grosman, B, Cantwell, M, et al.. Automated overnight closed-loop control using a proportional-integral-derivative algorithm with insulin feedback in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Technol Therapeut 2016;18:377–84. https://doi.org/10.1089/dia.2015.0431.Suche in Google Scholar PubMed
15. Ekhlaspour, L, Forlenza, GP, Chernavvsky, D, Maahs, DM, Wadwa, RP, Deboer, MD, et al.. Closed loop control in adolescents and children during winter sports: use of the Tandem Control-IQ AP system. Pediatr Diabetes 2019;20:759–68. https://doi.org/10.1111/pedi.12867.Suche in Google Scholar PubMed PubMed Central
16. Renard, E, Tubiana-Rufi, N, Bonnemaison-Gilbert, E, Coutant, R, Dalla-Vale, F, Farret, A, et al.. Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting. Diabetes Obes Metabol 2019;21:183–7. https://doi.org/10.1111/dom.13482.Suche in Google Scholar PubMed
17. Dovc, K, Macedoni, M, Bratina, N, Lepej, D, Nimri, R, Atlas, E, et al.. Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial. Diabetologia 2017;60:2157–67. https://doi.org/10.1007/s00125-017-4395-z.Suche in Google Scholar PubMed PubMed Central
18. Hovorka, R, Allen, JM, Elleri, D, Chassin, LJ, Harris, J, Xing, D, et al.. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743–51. https://doi.org/10.1016/s0140-6736(09)61998-x.Suche in Google Scholar
19. Haidar, A, Legault, L, Matteau-Pelletier, L, Messier, V, Dallaire, M, Ladouceur, M, et al.. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 2015;3:595–604. https://doi.org/10.1016/s2213-8587(15)00141-2.Suche in Google Scholar
20. Deckert, T, Bojsen, J, Christiansen, JS, Kølendorf, K, Svendsen, PA, Andersen, AR. 24-hour blood glucose profiles in insulin-dependent diabetics treated with intravenous insulin infusion systems. A comparison between closed- and open-loop systems. Acta Med Scand 1980;208:451–8. https://doi.org/10.1111/j.0954-6820.1980.tb01230.x.Suche in Google Scholar PubMed
21. de Bock, M, Dart, J, Hancock, M, Smith, G, Davis, EA, Jones, TW. Performance of medtronic hybrid closed-loop iterations: results from a randomized trial in adolescents with type 1 diabetes. Diabetes Technol Therapeut 2018;20:693–7. https://doi.org/10.1089/dia.2018.0161.Suche in Google Scholar PubMed
22. Del Favero, S, Boscari, F, Messori, M, Rabbone, I, Bonfanti, R, Sabbion, A, et al.. Randomized summer camp crossover trial in 5- to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe. Diabetes Care 2016;39:1180–5. https://doi.org/10.2337/dc15-2815.Suche in Google Scholar PubMed
23. DeBoer, MD, Breton, MD, Wakeman, C, Schertz, EM, Emory, EG, Robic, JL, et al.. Performance of an artificial pancreas system for young children with type 1 diabetes. Diabetes Technol Therapeut 2017;19:293–8. https://doi.org/10.1089/dia.2016.0424.Suche in Google Scholar PubMed
24. Eckstein, ML, Weilguni, B, Tauschmann, M, Zimmer, RT, Aziz, F, Sourij, H, et al.. Time in range for closed-loop systems versus standard of care during physical exercise in people with type 1 diabetes: a systematic review and meta-analysis. J Clin Med 2021;10. https://doi.org/10.3390/jcm10112445.Suche in Google Scholar PubMed PubMed Central
25. Moser, O, Eckstein, ML, West, DJ, Goswami, N, Sourij, H, Hofmann, P. Type 1 diabetes and physical exercise: moving (forward) as an adjuvant therapy. Curr Pharmaceut Des 2020;26:946–57. https://doi.org/10.2174/1381612826666200108113002.Suche in Google Scholar PubMed
26. Zaharieva, DP, Turksoy, K, McGaugh, SM, Pooni, R, Vienneau, T, Ly, T, et al.. Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes. Diabetes Technol Therapeut 2019;21:313–21. https://doi.org/10.1089/dia.2018.0364.Suche in Google Scholar PubMed PubMed Central
27. Dovc, K, Boughton, C, Tauschmann, M, Thabit, H, Bally, L, Allen, JM, et al.. Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery. Diabetes Care 2019;42:1344–7. https://doi.org/10.2337/dc18-2625.Suche in Google Scholar PubMed PubMed Central
28. Weisman, A, Bai, JW, Cardinez, M, Kramer, CK, Perkins, BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 2017;5:501–12. https://doi.org/10.1016/s2213-8587(17)30167-5.Suche in Google Scholar PubMed
29. Karageorgiou, V, Papaioannou, TG, Bellos, I, Alexandraki, K, Tentolouris, N, Stefanadis, C, et al.. Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis. Metabolism 2019;90:20–30. https://doi.org/10.1016/j.metabol.2018.10.002.Suche in Google Scholar PubMed
30. Kumareswaran, K, Elleri, D, Allen, JM, Harris, J, Xing, DY, Kollman, C, et al.. Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort. J Diabetes Sci Technol 2011;5:1352–62. https://doi.org/10.1177/193229681100500606.Suche in Google Scholar PubMed PubMed Central
31. Garg, SK, Weinzimer, SA, Tamborlane, WV, Buckingham, BA, Bode, BW, Bailey, TS, et al.. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Therapeut 2017;19:155–63. https://doi.org/10.1089/dia.2016.0421.Suche in Google Scholar PubMed PubMed Central
32. Forlenza, GP, Pinhas-Hamiel, O, Liljenquist, DR, Shulman, DI, Bailey, TS, Bode, BW, et al.. Safety evaluation of the MiniMed 670G system in children 7-13 Years of age with type 1 diabetes. Diabetes Technol Therapeut 2019;21:11–19. https://doi.org/10.1089/dia.2018.0264.Suche in Google Scholar PubMed PubMed Central
33. Sherr, JL, Buckingham, BA, Forlenza, GP, Galderisi, A, Ekhlaspour, L, Wadwa, RP, et al.. Safety and performance of the omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 Days under free-living conditions. Diabetes Technol Ther 2020;22:174. https://doi.org/10.1089/dia.2019.0286.Suche in Google Scholar PubMed PubMed Central
34. Van Name, MA, Hilliard, ME, Boyle, CT, Miller, KM, DeSalvo, DJ, Anderson, BJ, et al.. Nighttime is the worst time: parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes 2018;19:114–20. https://doi.org/10.1111/pedi.12525.Suche in Google Scholar PubMed PubMed Central
35. Kovatchev, B, Cheng, P, Anderson, SM, Pinsker, JE, Boscari, F, Buckingham, BA, et al.. Feasibility of long-term closed-loop control: a multicenter 6-month trial of 24/7 automated insulin delivery. Diabetes Technol Therapeut 2017;19:18. https://doi.org/10.1089/dia.2016.0333.Suche in Google Scholar PubMed
36. Buckingham, BA, Forlenza, GP, Pinsker, JE, Christiansen, MP, Wadwa, RP, Schneider, J, et al.. Safety and feasibility of the OmniPod hybrid closed-loop system in adult, adolescent, and pediatric patients with type 1 diabetes using a personalized model predictive control algorithm. Diabetes Technol Therapeut 2018;20:257–62. https://doi.org/10.1089/dia.2017.0346.Suche in Google Scholar PubMed PubMed Central
37. Tauschmann, M, Allen, JM, Wilinska, ME, Thabit, H, Acerini, CL, Dunger, DB, et al.. Home use of day-and-night hybrid closed-loop insulin delivery in suboptimally controlled adolescents with type 1 diabetes: a 3-week, free-living, randomized crossover trial. Diabetes Care 2016;39:2019–25. https://doi.org/10.2337/dc16-1094.Suche in Google Scholar PubMed PubMed Central
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/jpem-2024-0098).
© 2024 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Original Articles
- Incidences of newly diagnosed childhood diabetes and onset severity: a multicenter regional study in Thailand over two decades and during the COVID-19 pandemic
- Exploring ketoacidosis frequency and risk factors in childhood-onset type 1 diabetes: an 8-year retrospective study (2011–2018) at a tertiary paediatric hospital in Tripoli, Libya
- Automated insulin delivery in children with type 1 diabetes during physical activity: a meta-analysis
- Association between maternal and cord blood thyroid hormones, and urine iodine concentration with fetal growth
- Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin
- Familial dysalbuminemic hyperthyroxinemia (FDH) due to Arg242 His variant in ALB gene in Turkish children
- A novel useful marker in the early discrimination of transient hyperthyrotropinemia/hypothyroxinemia and congenital hypothyroidism in preterm infants: thyroid-stimulating hormone/free thyroxine ratio
- Comprehensive analyses of phenylalanine hydroxylase variants and phenotypic characteristics of patients in the eastern region of Türkiye
- Relationship between urinary sodium excretion and bone mineral density in pediatrics: population-based study from KNHANES V 2010–2011
- Trajectory of the body mass index of children and adolescents attending a reference mental health center
- Case Reports
- Prenatal presentation of a hyperfunctioning thyroid nodule
- A very rare presentation of mitochondrial elongation factor Tu deficiency-TUFM mutation and literature review
- Identification of a novel homozygous NR5A1 variant in a patient with a 46,XY disorders of sex development
- Use of [18F]fluorocholine PET/CT in the detection of primary hyperparathyroidism in paediatrics: a case report
Artikel in diesem Heft
- Frontmatter
- Original Articles
- Incidences of newly diagnosed childhood diabetes and onset severity: a multicenter regional study in Thailand over two decades and during the COVID-19 pandemic
- Exploring ketoacidosis frequency and risk factors in childhood-onset type 1 diabetes: an 8-year retrospective study (2011–2018) at a tertiary paediatric hospital in Tripoli, Libya
- Automated insulin delivery in children with type 1 diabetes during physical activity: a meta-analysis
- Association between maternal and cord blood thyroid hormones, and urine iodine concentration with fetal growth
- Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin
- Familial dysalbuminemic hyperthyroxinemia (FDH) due to Arg242 His variant in ALB gene in Turkish children
- A novel useful marker in the early discrimination of transient hyperthyrotropinemia/hypothyroxinemia and congenital hypothyroidism in preterm infants: thyroid-stimulating hormone/free thyroxine ratio
- Comprehensive analyses of phenylalanine hydroxylase variants and phenotypic characteristics of patients in the eastern region of Türkiye
- Relationship between urinary sodium excretion and bone mineral density in pediatrics: population-based study from KNHANES V 2010–2011
- Trajectory of the body mass index of children and adolescents attending a reference mental health center
- Case Reports
- Prenatal presentation of a hyperfunctioning thyroid nodule
- A very rare presentation of mitochondrial elongation factor Tu deficiency-TUFM mutation and literature review
- Identification of a novel homozygous NR5A1 variant in a patient with a 46,XY disorders of sex development
- Use of [18F]fluorocholine PET/CT in the detection of primary hyperparathyroidism in paediatrics: a case report